AI assistant
Instil Bio, Inc. — Director's Dealing 2023
Jan 20, 2023
33728_dirs_2023-01-20_96ef4955-72d7-47c6-a5a7-0686005ed0b6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2023-01-08
Reporting Person: Ray Sumita (Chief Legal and Admin Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-01-08 | Employee Stock Option (right to buy) | $0.634 | A | 415000 | Acquired | 2033-01-07 | Common Stock (415000.0) | Direct |
| 2023-01-18 | Employee Stock Option (right to buy) | $0.7709 | A | 50000 | Acquired | 2033-01-17 | Common Stock (50000.0) | Direct |
Footnotes
F1: Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
F2: Twenty-five percent (25%) of the shares subject to the option vest on January 18, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.